Vincerx Pharma Inc.

NASDAQ: VINC · Real-Time Price · USD
0.05
-0.00 (-1.96%)
At close: Jun 09, 2025, 12:40 PM

Vincerx Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-30.07M -40.16M -65.37M -39.31M
Depreciation & Amortization
1.09M 915K 939K 340K
Stock-Based Compensation
3.47M 3.56M 10.06M 23.31M
Other Working Capital
290K -2.95M -2.07M 4.08M
Other Non-Cash Items
-438K -583K -6.59M -23.36M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-178K -4.19M -1.02M 5.61M
Operating Cash Flow
-26.13M -40.45M -59.6M -33.4M
Capital Expenditures
n/a n/a n/a -5.26M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-11.46M -11.82M -42.98M n/a
Sales Maturities Of Investments
11.68M 53.32M 2.4M n/a
Other Investing Acitivies
n/a n/a -40.58K -5M
Investing Cash Flow
212K 41.5M -40.58M -5.26M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
118K 114K 280K 41.02M
Financial Cash Flow
17.99M 114K 280K 88.45M
Net Cash Flow
-7.79M 1.12M -99.83M 49.77M
Free Cash Flow
-26.13M -40.45M -59.6M -38.66M